期刊
TRENDS IN PHARMACOLOGICAL SCIENCES
卷 37, 期 5, 页码 390-411出版社
ELSEVIER SCIENCE LONDON
DOI: 10.1016/j.tips.2016.01.005
关键词
-
资金
- National Institutes of Health [NS055223, AG046710, AG042762, AG019070, AG051230]
- BrightFocus Foundation
- Cure Alzheimer's Fund
- Illinois Department of Public Health
- Alzheimer's Association
Amyloid precursor protein (APP) and its metabolites play a key role in Alzheimer's disease pathogenesis. The idea that APP may function as a receptor has gained momentum based on its structural similarities to type I transmembrane receptors and the identification of putative APP ligands. We review the recent experimental evidence in support of this notion and discuss how this concept is viewed in the field. Specifically, we focus on the structural and functional characteristics of APP as a cell surface receptor, and on its interaction with adaptors and signaling proteins. We also address the importance of APP function as a receptor in Alzheimer's disease etiology and discuss how this function might be potentially important for the development of novel therapeutic approaches.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据